Exports of Biosimilar Drugs to Get Boost (India)
This article was originally published in PharmAsia News
Executive Summary
The Indian Pharmaceutical Export Promotion Council (Pharmexcil) is developing a specific biotech export-program to promote biosimilar drugs because there is increasing demand for biosimilar drugs in the United States and Europe. Pharmexcil is looking to work with Indian industry groups on this. Experts believe that the biosimilar market by 2015 will total $30 billion in U.S. sales and $25 billion in European sales. (Click here for more